Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 18, 2026 16:05 ET | Source: TheRas, Inc. (d/b/a BBOT)

BBOT Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026

SOUTH SAN FRANCISCO, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway...
March 18, 2026 08:30 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Collaboration with University at Buffalo to Commercialize Novel Biomarkers for Sjögren’s Syndrome

DUBLIN and NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions,...
March 17, 2026 07:15 ET | Source: X4 Pharmaceuticals

X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

- Global 4WARD Phase 3 Chronic Neutropenia Trial On Track to Complete Enrollment in Q3 2026 - - Positive Opinion from European Medicines Agency Recommending Marketing Authorization of Mavorixafor for...
March 17, 2026 06:30 ET | Source: Avance Clinical

Avance Clinical Appoints Liahna Toy to Lead Global Early Phase Center of Excellence, Advancing Accelerated Early Phase Delivery for Biotechs

Avance Clinical Appoints Liahna Toy to Lead Global Early Phase Center of Excellence, Advancing Accelerated Early Phase Delivery for Biotechs
March 16, 2026 10:15 ET | Source: Exousia Pro, Inc.

Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value

OTC.MAJI Announces landmark agreement represents a pivotal financial milestone for the Company, delivering immediate and substantial value.
March 16, 2026 08:00 ET | Source: Cytokinetics, Incorporated

Cytokinetics Announces Four Presentations at the American College of Cardiology Annual Scientific Session & Expo

New Analyses from Three Trials in Obstructive HCM Support Findings from Previously Published Data on MYQORZO™ (aficamten) SOUTH SAN FRANCISCO, Calif., March 16, 2026 (GLOBE NEWSWIRE) --...
March 16, 2026 07:20 ET | Source: Dyadic International, Inc.

Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices

Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices
March 13, 2026 11:29 ET | Source: ProText Mobility, Inc.

ProText Mobility Inc. (OTC: TXTM) Updates Shareholders on Strategic Developments, Liquidity, and Stock Purchases

ProText Mobility Inc. (OTC: TXTM) Updates Shareholders on Strategic Developments, Liquidity, and Stock Purchases
March 12, 2026 16:05 ET | Source: Lyell Immunopharma, Inc

Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results

Patient dosing has commenced in first-of-its-kind Phase 3 head-to-head CAR T-cell 2L randomized controlled clinical trial (PiNACLE-H2H) in patients with large B-cell lymphoma, and the 3L+ pivotal...
March 12, 2026 11:55 ET | Source: Research and Markets

Pharmaceuticals and Biotechnology Joint Venture Terms and Agreement Analysis Report 2026: Valuable Insights Into Deal Structures, Financial Terms, and Partnership Strategies

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2026" report has been added to ResearchAndMarkets.com's offering.The Joint Venture...